Home Authors Posts by David Bogoslaw

David Bogoslaw

New Atomico report finds 8 in 10 European entrepreneurs say fundraising is harder this year. However, 45% say they are more confident in Europe’s ability to build global tech leaders than they were 12 months ago.
A new accelerator program from CEMEX Ventures is the latest in a growing number of projects rolled out by corporate venture funds in recent years to provide established industrial players with an inside track on evolving technologies.
Managing partners Nnamdi Okike and Aaron Holiday at 645 Ventures
The New York- and San Francisco-based firm raised $194.5m for its fourth flagship fund and another $153m for follow-on investments in its best-performing portfolio companies. 645 co-founders Aaron Holiday and Nnamdi Okike explain their strategy and share insights about the firm's value-added services.
Visionary, vision, looking, look, future, ahead
The Swedish firm has invested in 15 companies – two of which have had exits – that are led by women or immigrants or are located outside the Stockholm area.
A new program founded by Clara Wu Tsai’s Social Justice Fund, with support from Visible Hands and Blue Pool Capital, will provide capital and mentoring to underrepresented entrepreneurs.
EQT partner Lars Jörnow, who oversaw development of Candy Crush, explains why he is no longer excited about gaming, but instead focuses on companies serving the creator economy and electrification of traditional industries.
Columbia Business School professor Angela Lee speaks to VCJ about what’s holding women back in the venture industry and how she’s trying to prepare them for an expanded role.
The Liechtenstein Group, the investment arm of the princely family of one of Europe’s smallest countries, is seeking an inside track on tech to make its real estate holdings more sustainable.
Bigger funds with stellar track records have continued to raise capital at impressive rates, but will fundraising get harder as some LPs confront the denominator effect?
cancer cells, oncology, molecular
After raising $4.2m in pre-seed and seed funding, the Argentina-based biotech start-up is aiming to open a patient clinic by the end of 2023.
vcj
vcj

Copyright PEI Media

Not for publication, email or dissemination